OGN Relative Valuation
OGN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, OGN is overvalued; if below, it's undervalued.
Historical Valuation
Organon & Co (OGN) is now in the Undervalued zone, suggesting that its current forward PE ratio of 1.94 is considered Undervalued compared with the five-year average of 4.82. The fair price of Organon & Co (OGN) is between 29.40 to 37.91 according to relative valuation methord. Compared to the current price of 7.15 USD , Organon & Co is Undervalued By 75.68%.
Relative Value
Fair Zone
29.40-37.91
Current Price：7.15
75.68%
Undervalued
1.90
PE
1Y
3Y
5Y
Trailing
Forward
5.17
EV/EBITDA
Organon & Co. (OGN) has a current EV/EBITDA of 5.17. The 5-year average EV/EBITDA is 6.61. The thresholds are as follows: Strongly Undervalued below 4.37, Undervalued between 4.37 and 5.49, Fairly Valued between 7.73 and 5.49, Overvalued between 7.73 and 8.86, and Strongly Overvalued above 8.86. The current Forward EV/EBITDA of 5.17 falls within the Undervalued range.
5.90
EV/EBIT
Organon & Co. (OGN) has a current EV/EBIT of 5.90. The 5-year average EV/EBIT is 7.14. The thresholds are as follows: Strongly Undervalued below 4.74, Undervalued between 4.74 and 5.94, Fairly Valued between 8.34 and 5.94, Overvalued between 8.34 and 9.54, and Strongly Overvalued above 9.54. The current Forward EV/EBIT of 5.90 falls within the Undervalued range.
0.31
PS
Organon & Co. (OGN) has a current PS of 0.31. The 5-year average PS is 0.91. The thresholds are as follows: Strongly Undervalued below 0.21, Undervalued between 0.21 and 0.56, Fairly Valued between 1.25 and 0.56, Overvalued between 1.25 and 1.60, and Strongly Overvalued above 1.60. The current Forward PS of 0.31 falls within the Undervalued range.
1.86
P/OCF
Organon & Co. (OGN) has a current P/OCF of 1.86. The 5-year average P/OCF is 4.79. The thresholds are as follows: Strongly Undervalued below 1.48, Undervalued between 1.48 and 3.14, Fairly Valued between 6.45 and 3.14, Overvalued between 6.45 and 8.11, and Strongly Overvalued above 8.11. The current Forward P/OCF of 1.86 falls within the Undervalued range.
2.08
P/FCF
Organon & Co. (OGN) has a current P/FCF of 2.08. The 5-year average P/FCF is 5.72. The thresholds are as follows: Strongly Undervalued below 0.16, Undervalued between 0.16 and 2.94, Fairly Valued between 8.51 and 2.94, Overvalued between 8.51 and 11.29, and Strongly Overvalued above 11.29. The current Forward P/FCF of 2.08 falls within the Undervalued range.
Organon & Co (OGN) has a current Price-to-Book (P/B) ratio of 2.09. Compared to its 3-year average P/B ratio of 7.02 , the current P/B ratio is approximately -70.27% higher. Relative to its 5-year average P/B ratio of 2.79, the current P/B ratio is about -25.35% higher. Organon & Co (OGN) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 16.55%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 17.92% , the current FCF yield is about -100.00% lower.
2.05
P/B
Median3y
7.02
Median5y
2.79
41.11
FCF Yield
Median3y
16.55
Median5y
17.92
Competitors Valuation Multiple
The average P/S ratio for OGN's competitors is 0.00, providing a benchmark for relative valuation. Organon & Co Corp (OGN) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 1.26%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of OGN decreased by 51.26% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 3.61 to 3.73.
The secondary factor is the Revenue Growth, contributed 1.26%to the performance.
Overall, the performance of OGN in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is Organon & Co (OGN) currently overvalued or undervalued?
What is Organon & Co (OGN) fair value?
How does OGN's valuation metrics compare to the industry average?
What is the current P/B ratio for Organon & Co (OGN) as of Dec 05 2025?
What is the current FCF Yield for Organon & Co (OGN) as of Dec 05 2025?
What is the current Forward P/E ratio for Organon & Co (OGN) as of Dec 05 2025?